Abstract
Enterocutaneous fistulas, defined as abnormal communications between bowel and skin, are among the most challenging conditions managed by the general surgeon. In an era when the mortality from pan-creaticoduodenectomy is less than 3%, the mortality of enterocutaneous fistulas remains 10 to 30% due to the often-present complications of sepsis, malnutrition, and electrolyte abnormalities. Taking ad-vantage of recent advances in techniques of pre- and post-surgical management and support, employing a multidisciplinary team approach, and executing a well-delineated management plan provide the patient and surgeon with the best possibility of success in treating this potentially devastating condition.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Berry SM, Fischer JE. Classification and pathophysiology of enterocutaneous fistulas. Surg Clin North Am 1996;76:1009–1018.
Berry SM, Fischer JE. Enterocutaneous fistulas. In: Wells SA Jr, ed. Current Problems in Surgery, Vol. 31. St. Louis: Mosby, 1994, pp 469–576.
Edmunds LH, Williams GM, Welch CE. External fistulas arising from the gastrointestinal tract. Ann Surg 1960;152:445–471.
Levy E, Frileux P, Cugnenc PH, Honiger J, Ollivier JM, Parc R. High-output external fistulae of the small bowel: Management with continuous enteral nutrition. Br J Surg 1989;76:676–679.
Campos AC, Andrade DF, Campos GM. A multivariate model to determine prognostic factors in gastrointestinal fis-tulas. J Am Coll Surg 1999;188:483–490.
Soeters PB, Ebeid AM, Fischer JE. Review of 404 patients with gastrointestinal fistulas: Impact of parenteral nutrition. Ann Surg 1979;190:189–202.
Fischer JE. Gastrointestinal-cutaneous fistulae. In: Baker RJ, Fischer JE, eds. Mastery of Surgery, 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001, 1435–1441.
Fazio VS, Coutsoftides T, Steiger E. Factors influencing the outcome of treatment of small bowel cutaneous fistula. World J Surg 1983;7:481–488.
Hill GL, Bourchier RG, Witney GB. Surgical and metabolic management of patients with external fistulas of the small intestine associated with Crohn’s disease. World J Surg 1988;12:191–197.
Sitges-Serra A, Jaurrieta E, Sitges-Creus A. Management of post-operative enterocutaneous fistulas: The roles of paren-teral nutrition and surgery. Br J Surg 1982;69:147–150.
MacFadyen BV Jr, Dudrick SJ, Ruberg RL. Management of gastrointestinal fistulas with parenteral hyperalimentation. Surgery 1973;74:100–105.
Rose D, Yarborough MF, Canizaro PC, Lowry SF. One hundred and fourteen fistulas of the gastrointestinal tract treated with total parenteral nutrition. Surg Gynecol Obstet 1986;163:345–350.
Kuvshinoff BW, Brodish RH, McFadden DW, Fischer JE. Serum transferrin as a prognostic indicator of spontaneous closure and mortality in gastrointestinal cutaneous fistulas. Ann Surg 1993;217:615–622.
Chintapatla S, Scott NA. Intestinal failure in complex gastro-intestinal fistualae. Nutrition 2002;18:991–995.
Wang X, Ren J, Li J. Sequential changes of body composition in patients with enterocutaneous fistula during the 10 days af-ter admission. World J Gastroenterol 2002;8:1149–1152.
Cox-Reijven PL, van Kreel B, Soeters PB. Bioelectrical impedance measurements in patients with gastrointestinal disease: Validation of the spectrum approach and a compari-son of different methods for screening for nutritional deple-tion. Am J Clin Nutr 2003;78:1111–1119.
Reber HA, Roberts C, Way LW, Dunphy JE. Management of external gastrointestinal fistulas. Ann Surg 1978;188:460–467.
Foster CE III, Lefor AT. General management of gastroin-testinal fistulas: Recognition, stabilization, and correction of fluid and electrolyte imbalances. Surg Clin North Am 1996; 76:1019–1033.
Alivizatos V, Felekis D, Zorbalas A. Evaluation of the effec-tiveness of octreotide in the conservative treatment of post-operative enterocutaneous fistulas. Hepatogastroenterology 2002;49:1010–1012.
Martineu, Shwed JA, Denis R. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure? Am J Surg 1996;172:386–395.
Hesse U, Ysebaert D, Hemptinne B. Role of somatostatin-14 and its analogues in the management of gastrointestinal fistu-lae: Clinical data. Gut 2002;49(Suppl IV):iv11-iv20.
Torres AJ, Land JI, Moreno-Azcoita M, et al. Somatostatin in the management of gastrointestinal fistulas. A multicenter trial. Arch Surg 1992;127:97–99.
Sancho JJ, di Costanzo J, Nubiola P, et al. Randomized dou-bleblind placebo-controlled trial of early octreotide in pa-tients with postoperative enterocutaneous fistula. Br J Surg 1995;82:638–641.
Nubiola-Calonge P, Badia JM, Sancho J, Gil MJ, Segura M, Sitges-Serra A. Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fis-tula output. Lancet 1987;2:672–674.
Hernandez-Aranda JC, Gallo-Chico B, Flores-Ramirez LA, Avalos-Huante R, Magos-Vazquez FJ, Ramirez-Barba EJ. Treatment of enterocutaneous fistulae with or without octreotide and parenteral nutrition. Nutr Hosp 1996;11:226–229.
Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 1999;340:1398–1405.
Viscido A, Habib FI, Kohn A, et al. Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis. Aliment Pharmacol Ther 2003;17:1263–1271.
Erdmann D, Drye C, Heller L, Wong MS, Levin SL. Ab-dominal wall defect and enterocutaneous fistula treatment with the vacuum-assisted closure (VAC) system. Plast Re-constr Surg 2001;108:2066–2068.
Alvarez AA, Maxwell GL, Rodriquez GC. Vacuum-assisted closure for cutaneous gastrointestinal fistula management. Gynecol Oncol 2001;80:413–416.
Cro C, George KJ, Donnelly J, Irwin ST, Gardiner KR. Vacuum assisted closure system in the management of enter-ocutaneous fistulae. Postgrad Med J 2002;78:364–365.
Falconi M, Sartori N, Caldiron E, Salvia R, Bassi C, Pederzoli P. Management of digestive tract fistulas: A review. Digestion 1999;60(Suppl 3):51–58.
Aguirre A, Fischer JE, Welch CE. The role of surgery and hyperalimentation in therapy of gastrointestinal-cutaneous fistulae. Ann Surg 1974;180:393–401.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Evenson, A.R., Fischer, J.E. Current management of enterocutaneous fistula. J Gastrointest Surg 10, 455–464 (2006). https://doi.org/10.1016/j.gassur.2005.08.001
Issue Date:
DOI: https://doi.org/10.1016/j.gassur.2005.08.001